Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis

 

Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes

 

The endocannabinoid system of the skin in health and disease: Novel perspectives and therapeutic opportunities

 

Epigenetic control of skin differentiation genes by phytocannabinoids

 

Endocannabinoids modulate human epidermal keratinocyte proliferation and survival via the sequential engagement of cannabinoid receptor-1 and transient receptor potential vanilloid-1

 

Cannabinoid 1 receptors in keratinocytes modulate proinflammatory chemokine secretion and attenuate contact allergic inflammation

 

Attenuation of allergic contact dermatitis through the endocannabinoid system

 

Topical cannabinoid agonists. An effective new possibility for treating chronic pruritus